Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 3/2012

01-03-2012 | Original Article

Intraluminal pH and Goblet Cell Density in Barrett’s Esophagus

Authors: Dimitrios Theodorou, Shahin Ayazi, Steven R. DeMeester, Joerg Zehetner, Christian G. Peyre, Kimberly S. Grant, Florian Augustin, Daniel S. Oh, John C. Lipham, Parakrama T. Chandrasoma, Jeffrey A. Hagen, Tom R. DeMeester

Published in: Journal of Gastrointestinal Surgery | Issue 3/2012

Login to get access

Abstract

Introduction

Goblet cells in Barrett’s esophagus (BE) vary in their density within the Barrett’s segment. Exposure of Barrett’s epithelium to bile acids is a major stimulant for goblet cell formation. The dissociation of bile acids into forms that penetrate Barrett’s epithelium is known to be pH dependent. We hypothesized that variations in the esophageal luminal pH environment explains the variability in goblet cell density. The aim of this study was to correlate esophageal luminal pH with goblet cell density in patients with BE.

Methods

A customized six-sensor pH catheter was positioned with the most distal sensor in the stomach and the remaining sensors located 1 cm below and 1, 3, 5, and 8 cm above the upper border of the lower esophageal sphincter in five normal subjects and six patients with long-segment BE. The luminal pH was measured by each sensor for 24-h and expressed as median pH. Patients with BE had four quadrant biopsies at levels corresponding to the location of the pH sensors. Goblet cell density was graded from 0 to 3 based on the number per high-power field.

Results

In normal subjects, the median pH values recorded in the sensors within the lower esophageal sphincter (LES) and esophageal body were all above 5. In patients with BE, the median pH recorded by the sensor within the LES was 2.8 and increased progressively to 4.7 in the sensor at 8 cm above the LES. Goblet cell density was significantly lower in the distal Barrett’s segment exposed to a median pH of 2.2 and increased in the proximal Barrett’s segment exposed to a median pH of 4.4 (p = 0.003).

Conclusion

Patients with BE have a goblet cell gradient that correlates directly with an esophageal luminal pH gradient. This suggests that goblet cell differentiation is pH dependent and likely due to the effect of pH on bile acid dissociation.
Literature
1.
go back to reference Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976; 295(9):476–80.PubMedCrossRef Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976; 295(9):476–80.PubMedCrossRef
2.
go back to reference Oberg S, Peters JH, DeMeester TR, et al. Determinants of intestinal metaplasia within the columnar-lined esophagus. Arch Surg. 2000 Jun; 135(6):651–5; discussion 655–6PubMedCrossRef Oberg S, Peters JH, DeMeester TR, et al. Determinants of intestinal metaplasia within the columnar-lined esophagus. Arch Surg. 2000 Jun; 135(6):651–5; discussion 655–6PubMedCrossRef
3.
go back to reference Ayazi S, Leers JM, Oezcelik A, et al. Measurement of gastric pH in ambulatory esophageal pH monitoring. Surg Endosc. 2009 Sep; 23(9):1968–73PubMedCrossRef Ayazi S, Leers JM, Oezcelik A, et al. Measurement of gastric pH in ambulatory esophageal pH monitoring. Surg Endosc. 2009 Sep; 23(9):1968–73PubMedCrossRef
4.
go back to reference Zaninotto G, DeMeester TR, Schwizer W, et al. The lower esophageal sphincter in health and disease. Am J Surg. 1988;155(1):104–111PubMedCrossRef Zaninotto G, DeMeester TR, Schwizer W, et al. The lower esophageal sphincter in health and disease. Am J Surg. 1988;155(1):104–111PubMedCrossRef
5.
go back to reference Ayazi S, Hagen JA, Zehetner J, et al. Day to day discrepancy in bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease. Surg Endosc. 2011; 25(7):2219–23.PubMedCrossRef Ayazi S, Hagen JA, Zehetner J, et al. Day to day discrepancy in bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease. Surg Endosc. 2011; 25(7):2219–23.PubMedCrossRef
6.
go back to reference Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. The American Journal of Gastroenterology 2002; 97(8):1888–1895.PubMedCrossRef Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. The American Journal of Gastroenterology 2002; 97(8):1888–1895.PubMedCrossRef
7.
go back to reference Chandrasoma PT, Der R, Dalton P, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol. 2001; 25(9):1188–93.PubMedCrossRef Chandrasoma PT, Der R, Dalton P, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol. 2001; 25(9):1188–93.PubMedCrossRef
8.
go back to reference Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg. 2001 Nov;136(11):1267–73.PubMedCrossRef Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg. 2001 Nov;136(11):1267–73.PubMedCrossRef
9.
go back to reference Schweitzer EJ, Bass BL, Batzri S, Harmon JW. Bile acid accumulation by rabbit esophageal mucosa. Digestive Diseases & Sciences 1986; 31(10):1105–13.CrossRef Schweitzer EJ, Bass BL, Batzri S, Harmon JW. Bile acid accumulation by rabbit esophageal mucosa. Digestive Diseases & Sciences 1986; 31(10):1105–13.CrossRef
10.
go back to reference Schweitzer EJ, Bass BL, Batzri S, Harmon JW. Esophageal mucosa: a bile acid sink in the rabbit. Surgical Forum 1983; 34:152–3. Schweitzer EJ, Bass BL, Batzri S, Harmon JW. Esophageal mucosa: a bile acid sink in the rabbit. Surgical Forum 1983; 34:152–3.
11.
go back to reference Hu Y, Jones C, Gellersen O, Williams VA, et al. Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg. 2007 Jun; 142(6):540–4; discussion 544–5PubMedCrossRef Hu Y, Jones C, Gellersen O, Williams VA, et al. Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg. 2007 Jun; 142(6):540–4; discussion 544–5PubMedCrossRef
12.
go back to reference Souza RF, Krishnan K, Spechler SJ. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol. 2008 Aug; 295(2):G211-8.PubMedCrossRef Souza RF, Krishnan K, Spechler SJ. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol. 2008 Aug; 295(2):G211-8.PubMedCrossRef
13.
go back to reference Oh, DS; DeMeester, SR; Mori, R, et al. Sonic hedgehog gene expression in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2008, 134: A150. Oh, DS; DeMeester, SR; Mori, R, et al. Sonic hedgehog gene expression in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2008, 134: A150.
14.
go back to reference Möbius C, Stein HJ, Spiess C, Becker I, et al. COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer. Eur J Surg Oncol. 2005 Sep; 31(7):755–9.PubMedCrossRef Möbius C, Stein HJ, Spiess C, Becker I, et al. COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer. Eur J Surg Oncol. 2005 Sep; 31(7):755–9.PubMedCrossRef
15.
go back to reference Cronin J, McAdam E, Danikas A, et al. Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE). Am J Gastroenterol. 2011 Jan; 106(1):46–56.PubMedCrossRef Cronin J, McAdam E, Danikas A, et al. Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE). Am J Gastroenterol. 2011 Jan; 106(1):46–56.PubMedCrossRef
16.
go back to reference Tselepis C, Morris CD, Wakelin D, et al. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut. 2003 Feb; 52(2):174–80.PubMedCrossRef Tselepis C, Morris CD, Wakelin D, et al. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut. 2003 Feb; 52(2):174–80.PubMedCrossRef
17.
go back to reference Umansky M , Yasui W, Hallak A, et al. Proton pump inhibitors reduce cell cycle abnormalities in Barrett’s esophagus. Oncogene2001; 20:7987–91.PubMedCrossRef Umansky M , Yasui W, Hallak A, et al. Proton pump inhibitors reduce cell cycle abnormalities in Barrett’s esophagus. Oncogene2001; 20:7987–91.PubMedCrossRef
18.
go back to reference Theisen J, Peters JH, Fein M, et al. The mutagenic potential of duodenoesophageal reflux. Annals of Surgery 2005; 241(1):63–8.PubMed Theisen J, Peters JH, Fein M, et al. The mutagenic potential of duodenoesophageal reflux. Annals of Surgery 2005; 241(1):63–8.PubMed
19.
go back to reference Bernstein H, Bernstein C, Payne CM, et al. Bile acids as carcinogens in human gastrointestinal cancers. Mutation Research 2005; 589(1):47–65.PubMedCrossRef Bernstein H, Bernstein C, Payne CM, et al. Bile acids as carcinogens in human gastrointestinal cancers. Mutation Research 2005; 589(1):47–65.PubMedCrossRef
Metadata
Title
Intraluminal pH and Goblet Cell Density in Barrett’s Esophagus
Authors
Dimitrios Theodorou
Shahin Ayazi
Steven R. DeMeester
Joerg Zehetner
Christian G. Peyre
Kimberly S. Grant
Florian Augustin
Daniel S. Oh
John C. Lipham
Parakrama T. Chandrasoma
Jeffrey A. Hagen
Tom R. DeMeester
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 3/2012
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1776-3

Other articles of this Issue 3/2012

Journal of Gastrointestinal Surgery 3/2012 Go to the issue